Drs Byram Bridle and Sarah Wootton receive grants from the Canadian Cancer Society Research Institute and CHIR

Dr. Byram Bridle received an Innovation Grant worth $200,000 over two years, which is jointly funded by the Canadian Cancer Society Research Institute and CIHR (Institute of Cancer Research). The project is entitled "Combining Oncolytic Virotherapy and Epigenetic Modifiers to Treat Acute Leukemias".

Drs. Byram Bridle and Sarah Wootton received an Operating Grant worth $120,000 over two years, which is jointly funded by the Cancer Research Society and CIHR (Institute of Cancer Research). The project is entitled "Treatment of Osteosarcoma Lung Metastases with an Infected Cancer Cell Vaccine"